David Randolph Collins, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| vpr Gene Products, Human Immunodeficiency Virus | 3 | 2020 | 41 | 0.980 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 4115 | 0.740 |
Why?
|
| Viremia | 1 | 2021 | 684 | 0.710 |
Why?
|
| AIDS Vaccines | 2 | 2020 | 887 | 0.640 |
Why?
|
| HIV-1 | 6 | 2020 | 6711 | 0.540 |
Why?
|
| HIV Infections | 6 | 2021 | 14979 | 0.440 |
Why?
|
| Capsid Proteins | 1 | 2014 | 460 | 0.420 |
Why?
|
| Immune Evasion | 1 | 2014 | 337 | 0.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4355 | 0.380 |
Why?
|
| Macrophages | 4 | 2020 | 5748 | 0.380 |
Why?
|
| Virion | 2 | 2015 | 426 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2020 | 1959 | 0.220 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 104 | 0.200 |
Why?
|
| Macrolides | 1 | 2020 | 222 | 0.190 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 882 | 0.160 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 617 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2019 | 878 | 0.140 |
Why?
|
| Immunization | 1 | 2020 | 1280 | 0.140 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2014 | 129 | 0.140 |
Why?
|
| Gene Products, gag | 1 | 2014 | 347 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1577 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1734 | 0.130 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 347 | 0.120 |
Why?
|
| Retroviridae | 1 | 2014 | 986 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1516 | 0.110 |
Why?
|
| Interferon-alpha | 1 | 2015 | 925 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1572 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2157 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2020 | 1513 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 2944 | 0.100 |
Why?
|
| Recurrence | 1 | 2021 | 8198 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2014 | 2823 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2014 | 3982 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2020 | 1536 | 0.060 |
Why?
|
| Virus Replication | 2 | 2020 | 2589 | 0.050 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 163 | 0.050 |
Why?
|
| Gene Products, nef | 1 | 2020 | 110 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2020 | 261 | 0.050 |
Why?
|
| Humans | 10 | 2021 | 686663 | 0.050 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 239 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2014 | 3395 | 0.040 |
Why?
|
| HLA-B Antigens | 1 | 2019 | 411 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2019 | 1280 | 0.040 |
Why?
|
| Protein Binding | 2 | 2020 | 9947 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2020 | 20620 | 0.030 |
Why?
|
| Interferons | 1 | 2014 | 610 | 0.030 |
Why?
|
| Proteome | 1 | 2019 | 1707 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 7140 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 211400 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 216468 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1826 | 0.020 |
Why?
|
| Male | 1 | 2021 | 352465 | 0.020 |
Why?
|
| Female | 1 | 2021 | 375459 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 170849 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5257 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 28848 | 0.010 |
Why?
|